Winston Medical Supply Co., Ltd.
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use pr… Read more
Winston Medical Supply Co., Ltd. (6817) - Net Assets
Latest net assets as of June 2025: NT$376.95 Million TWD
Based on the latest financial reports, Winston Medical Supply Co., Ltd. (6817) has net assets worth NT$376.95 Million TWD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$858.66 Million) and total liabilities (NT$481.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$376.95 Million |
| % of Total Assets | 43.9% |
| Annual Growth Rate | 20.51% |
| 5-Year Change | 54.97% |
| 10-Year Change | N/A |
| Growth Volatility | 21.58 |
Winston Medical Supply Co., Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Winston Medical Supply Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Winston Medical Supply Co., Ltd. (2019–2024)
The table below shows the annual net assets of Winston Medical Supply Co., Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$439.38 Million | +2.68% |
| 2023-12-31 | NT$427.90 Million | +18.31% |
| 2022-12-31 | NT$361.67 Million | +11.19% |
| 2021-12-31 | NT$325.28 Million | +14.73% |
| 2020-12-31 | NT$283.52 Million | +64.09% |
| 2019-12-31 | NT$172.79 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Winston Medical Supply Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 37697300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$191.53 Million | 43.59% |
| Common Stock | NT$184.17 Million | 41.92% |
| Other Components | NT$63.68 Million | 14.49% |
| Total Equity | NT$439.38 Million | 100.00% |
Winston Medical Supply Co., Ltd. Competitors by Market Cap
The table below lists competitors of Winston Medical Supply Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VULCAN MINLS
F:VM3
|
$16.91 Million |
|
Lii Hen Industries Bhd
KLSE:7089
|
$16.92 Million |
|
MorphoSys AG
PINK:MPSYF
|
$16.92 Million |
|
PROLOGUE S.A.INH.B EO-30
F:69P
|
$16.92 Million |
|
Circio Holding ASA
OL:CRNA
|
$16.90 Million |
|
Ai-Media Technologies Ltd
AU:AIM
|
$16.90 Million |
|
Openn Negotiation Limited
PINK:OPNNF
|
$16.90 Million |
|
6969
TW:6969
|
$16.90 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Winston Medical Supply Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 427,901,000 to 439,382,000, a change of 11,481,000 (2.7%).
- Net income of 131,593,000 contributed positively to equity growth.
- Dividend payments of 121,552,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$131.59 Million | +29.95% |
| Dividends Paid | NT$121.55 Million | -27.66% |
| Other Changes | NT$1.44 Million | +0.33% |
| Total Change | NT$- | 2.68% |
Book Value vs Market Value Analysis
This analysis compares Winston Medical Supply Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.00x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.44x to 3.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | NT$4.94 | NT$71.30 | x |
| 2020-12-31 | NT$8.08 | NT$71.30 | x |
| 2021-12-31 | NT$17.63 | NT$71.30 | x |
| 2022-12-31 | NT$19.55 | NT$71.30 | x |
| 2023-12-31 | NT$23.13 | NT$71.30 | x |
| 2024-12-31 | NT$23.76 | NT$71.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Winston Medical Supply Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 29.95%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.93%
- • Asset Turnover: 0.86x
- • Equity Multiplier: 1.85x
- Recent ROE (29.95%) is above the historical average (25.98%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -5.42% | -2.56% | 0.59x | 3.55x | NT$-26.64 Million |
| 2020 | 35.16% | 19.73% | 0.77x | 2.32x | NT$71.33 Million |
| 2021 | 28.32% | 17.17% | 0.84x | 1.96x | NT$59.60 Million |
| 2022 | 30.76% | 18.34% | 0.86x | 1.94x | NT$75.09 Million |
| 2023 | 37.10% | 22.39% | 0.88x | 1.87x | NT$115.96 Million |
| 2024 | 29.95% | 18.93% | 0.86x | 1.85x | NT$87.65 Million |
Industry Comparison
This section compares Winston Medical Supply Co., Ltd.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $3,317,013,700
- Average return on equity (ROE) among peers: 4.53%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Winston Medical Supply Co., Ltd. (6817) | NT$376.95 Million | -5.42% | 1.28x | $16.91 Million |
| Grape King Bio Ltd (1707) | $2.08 Billion | 18.27% | 0.54x | $415.70 Million |
| Standard Chemical & Pharmaceutical Co Ltd (1720) | $4.20 Billion | 8.11% | 0.48x | $159.99 Million |
| Maywufa Co Ltd (1731) | $1.41 Billion | 2.15% | 1.10x | $41.61 Million |
| Allied Biotech Corporation (1780) | $1.08 Billion | 1.21% | 1.26x | $48.27 Million |
| ScinoPharm Taiwan Ltd (1789) | $10.36 Billion | 2.77% | 0.13x | $179.96 Million |
| GeneFerm Biotechnology Co Ltd (1796) | $396.19 Million | 1.14% | 1.48x | $23.77 Million |
| Easywell Biomedicals Inc. (1799) | $623.80 Million | -23.22% | 0.95x | $82.61 Million |
| LIWANLI Innovation Co Ltd (3054) | $897.52 Million | 5.08% | 0.06x | $51.25 Million |
| YungShin Global Holding Corp (3705) | $5.90 Billion | 12.21% | 0.47x | $295.98 Million |
| TTY Biopharm Co Ltd (4105) | $6.23 Billion | 17.56% | 0.54x | $484.94 Million |